作者: E. Tamayo Aguirre , A. Galo-Anza , O. Dorronsoro-Barandiaran , E. Uranga-Saez del Burgo , A. Ostiza Irigoyen
DOI: 10.1186/S12872-016-0326-Z
关键词: Prospective cohort study 、 Patient satisfaction 、 Intensive care medicine 、 Intervention (counseling) 、 Polypharmacy 、 Self-management 、 Physical therapy 、 Anticoagulant 、 Selection bias 、 Medicine 、 Quality of life (healthcare)
摘要: Self-management may be an option to monitor oral anticoagulant therapy in health systems, but before recommending it, we need assess patients’ ability take on this task. The purpose of the study was describe self-manage and associated factors. This a 3-year prospective quasi-experimental with control group. Overall, 333 patients from seven primary care centres Basque Health Service were included intervention group followed up for 6 months after intervention, assessing their self-test self-manage. consisted patient training programme, providing detailed information condition its treatment, practical how use portable blood coagulation adjust dose. Comparisons made (333 receiving OAT under usual same centres). Outcome variables self-manage, quality outcome (in terms time therapeutic range), life group, general characteristics (age sex), clinical (reason OAT, INR percentage measurements range complications) both groups. 26.13 % invited participate agreed. Of these, 99 successfully learned OAT. Just 4.2 did not complete follow-up, all cases reasons unrelated self-management, 4.5 required additional learning support. Outcomes better than (12 %), rate complications (4 %) (9.2 %). Patients only followed-up period conducted single organization. Though eligible selected randomly, they randomly allocated is potential source selection bias. Data needed calculate in-range collected controls; rather results self-management compared external data other studies. Almost participants achieved competency no differences by age, sex, concurrent illnesses, polypharmacy or educational level. greatest barrier attitude themselves those around them. good alternative care, having longer times fewer complications, improving life. Remote management support tool. ClinicalTrials.gov Identifier: NCT01878539.